1. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340(2): 115-126.
2. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65(5): 297-302.
3. Mauviel A. Cytokine regulation of metallopro­teinase gene expression. J Cell Biochem 1993; 53(4): 288-295.
4. Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 1996; 8(11): 817-821.
5. Morin L, Schlaepfer IR, Eckel RH. Tumor necrosis factor-a eliminates binding of NF-g and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. J Clin Invest 1995; 95(4): 1684-1689.
6. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234(4775): 470-474.
7. Tracey KJ Lowry SF, Fahey TJ Albert JD, Fong Y, Hesse DJ, Beutler B, Manogue KR, Calvano SE, Wei H, Cerami A, Shires GT. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164(5): 415-422.
8. Campbell RD, Trowsdale J. Map of human MHC. Immunol Today 1993; 14(7): 349-352.
9. Wilson AG, di Giovane FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF a) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1(5): 353.
10. Wilson AG, Symons JA, McDowell TL, di Giovane FS, Duff GW. Effect of tumour necrosis factor (TNF a) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33(1): 89.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effect of polymorphism in the human tumor necrosis factor a promoter on transition on transcrip­tional activation. Proc Natl Acad Sci 1997; 94(7): 3195-3199.
12. Pavlikova EP, Merai IA. Clinical significance of interleukin-6 and tumor necrosis factor-a in ischemic heart disease. Cardiology 2003; 8(1): 68-71.
13. Mathew CC. The isolation of high molecular weight eukaryotic DNA. In: Walker JM, ed. Methods in Molecular Biology. New York: Humana Press. 1984; 31-34.
14. Roff PA, Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: chi 2 and the problem of small samples. Mol Biol Evol 1989; 6(5): 539-545.
15. Zhivotovsky LA. Population Biometrics. Moscow: Nauka, 1991.
16. Schlesseman J. Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press, 1982.
17. Allen RA, Lee EM, Roberts DH, Park BK, Pirmo­hamed M. Polymorphism in the TNF-a and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 2001; 31(10): 843-851.
18. Keso T, Perola M, Laippala P, Ilveskovsky E, Kunnas TA, Mikkelson J, Penttila A, Hurme M, Karhunen PJ. Polymorphism within the tumor necrosis factor locus and prevalence of coronary artery disease and middle-aged men. Atherosclerosis 2001; 154(3): 691-697.
19. Padovani LC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphism in the TNF locus and risk of myocardial infarction. Thromb Res 2000; 100(4): 263-269.
20. Koch W, Kastrati A, Bottiger C, Mehilli J, Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphism and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159(1): 137-144.
21. Poli F, Nocco A, Berra S, Scalamogna E, Taioli E, Londhi E, Sirchia G. Allele frequencies of polymor­phisms of TNFA, IL-6, IL-10 and IFNG in an Italian Cau­casian population. Eur J Immunogen 2002; 29(3): 237-240.
22. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, Mbena JE, Mabey DC. Scarring trachoma is associated with polymorphism in the tumor necrosis factor a (TNF-a) gene promoter and with elevated TNF-a levels in tear fluid. Infect Immun 1997; 65(3): 1003-1006.
23. Higuchi T, Seki N, Kamisono S, Uamada A, Kato H, Itoh K. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-a gene in Japanese. Tissue Antigens 1998; 51(6): 605-612.
24. Herrmann SM, Ricards S, Nicaud V, Mallet C, Arveiler D, Evans A, Rudavets JB, Luc K, Bara MT, Carrera-Parra LF, Poirier J. Polymorphism of the tumor necrosis factor-a gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28(1): 59-66.
25. Elghannam H, Tavackoli S, Ferlic L, Gotto AM, Ballantyne CM, Marian AJ. A prospective study of genetic markers of susceptibility to infection and inflammation, and severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med 2000; 78(10): 562-568.